Pluri Inc. 2024 Investor Presentation - Cell Expansion Technology

Pluri Inc. is a biotech company offering robust cell expansion technology platforms to create cell-based solutions addressing aging, health, sustainability, climate change, and food security. The company develops innovative cell therapy applications, including PLX-PAD for muscle regeneration and PLX-R18 for bone marrow regeneration, while exploring applications in agriculture through partnerships.